Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Small Molecules
Filter     Order     Display # 
Date Item Title
08 Jul 2008 Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
08 Jul 2008 Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
08 Jul 2008 LifeCycle Pharma Announces Positive Topline Results from Phase II Clinical Study of LCP-Tacro Once Daily in Stable Liver Transplant Patients
08 Jul 2008 Sciele Pharma Completes Phase III Safety Trial for Glycopyrrolate Liquid, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients
08 Jul 2008 Akela Pharma repeats its Fentanyl TAIFUN(R) preclinical toxicology studies
08 Jul 2008 Giaconda Limited Suspends Hepaconda Phase II Trial to Carry Out Dose Ranging
07 Jul 2008 Hana Biosciences Presents Alocrest and Menadione Data At the European Society for Medical Oncology Conference
07 Jul 2008 Pulmo BioTech Inc. Completes Bio-Distribution Studies
07 Jul 2008 Laboratorios Almirall, S.A. and Forest Laboratories, Inc. complete Phase III Studies in COPD
03 Jul 2008 Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients
03 Jul 2008 ARYx Therapeutics, Inc. Announces Procter & Gamble Exercises Option to End Collaboration on ATI-7505
03 Jul 2008 Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
03 Jul 2008 Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study
03 Jul 2008 ARYx Therapeutics, Inc. Announces Successful Results of QT Study on ATI-7505
03 Jul 2008 SkyePharma Announces Third Flutiform(TM) Phase III Efficacy Study Meets Primary Endpoints and Completes Original Core Clinical Trial Programme
01 Jul 2008 Proton Pump Inhibitor ACIPHEX(R) 20 mg Receives Approvalfor Short-Term Treatment of GERD in Adolescents in United States
01 Jul 2008 Ore Pharmaceuticals Files Investigational New Drug Application with FDA
01 Jul 2008 Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
01 Jul 2008 Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration
01 Jul 2008 EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
01 Jul 2008 SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
01 Jul 2008 SCOLR Pharma, Inc. Advances Extended-Release Ibuprofen with Initiation of Clinical Study
01 Jul 2008 Salix Initiates Phase 3 for Rifaximin in Non–Constipation Irritable Bowel Syndrome
30 Jun 2008 New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
30 Jun 2008 Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
30 Jun 2008 Indevus Receives Approvable Letter from FDA for NEBIDO(R)
30 Jun 2008 DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or With Plavix(TM) or Aspirin
30 Jun 2008 Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
30 Jun 2008 Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
30 Jun 2008 SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
30 Jun 2008 Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal(R) as Compared to Topical Testim(R) Examining Effects on Male Fertility and Testicular Function
30 Jun 2008 Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death
30 Jun 2008 NuPathe Reports Positive Phase I Results for NP101, a Novel Transdermal Patch for Acute Migraine
30 Jun 2008 Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
30 Jun 2008 Data Presented at American Headache Society’s Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics’ Tezampanel
30 Jun 2008 Headline results of Flurizan(R) in clinical phase III trial
29 Jun 2008 UCB's Vimpat(TM) recommended for approval in Europe for epilepsy
29 Jun 2008 Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
29 Jun 2008 European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
29 Jun 2008 Bosentan (Tracleer(R)) receives positive EU opinion for treatment of patients with mildly symptomatic WHO Functional Class II pulmonary arterial hypertension
29 Jun 2008 FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
29 Jun 2008 Merck's Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study
29 Jun 2008 iCo Therapeutics Reports New iCo-009 (Oral Amphotericin B) Preclinical Results
29 Jun 2008 Orexo report Abstral (Rapinyl) approval in Europe
29 Jun 2008 Liver Phase I Results Presented at WCIO 2008 & Best of ASCO(R)
29 Jun 2008 MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
29 Jun 2008 Optimer Reports Additional Data on Investigational Compound OPT-80 at Anaerobe 2008 Congress
26 Jun 2008 Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the Treatment of Opioid Dependence
26 Jun 2008 Avalon Pharmaceuticals Nominates Lead Clinical Development Candidate in its Beta-catenin Pathway Inhibitor Program
26 Jun 2008 Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 201 - 250 of 5215

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics